About Us
Welcome to the OHSU Department of Pathology and Laboratory Medicine!
Pathology and Laboratory Medicine is a dynamic academic department, providing world-class clinical care to our patients, fostering expanded basic science and research programs, innovating pathology education, and pursuing new advancements in patient care, teaching, and research. Using technology such as remote frozen section interpretation, we are improving turnaround times and the work-life balance of our physicians. Our collaborative work environment includes a junior faculty mentorship program, internal leadership opportunities, annual faculty retreat, faculty workgroups, and regular opportunities to share feedback and ideas as we strive for continuous program improvement. Our learners are integral members of our department, and our faculty are passionate educators. Collegiality, collaboration and a love of learning define us as a team of academic physicians and physicians in training.
Education
We pride ourselves on our enthusiastic, dedicated teachers, the comradery in our learners, and our devotion to the best of academic medicine. We offer an excellent residency program and five subspecialty fellowships. Our educational offerings also include the unique Pathology Student Fellowship, four medical student electives, visiting pathologists’ assistant student, and a pathology interest group. Our CME program regularly invites nationally recognized visiting speakers.
Clinical Care
Our pathologists provide exceptional diagnostic care for patients in OHSU Hospital, OHSU Clinics, Doernbecher’s Children’s Hospital, Portland Veterans Affairs Medical Center, and Shriner’s Hospitals for Children. In addition, we offer second opinions for patients as well as consultations for physicians throughout the Pacific Northwest and across the country. Our highly trained, subspecialized providers are devoted to providing state-of-the-art personalized medicine, integrating each patient’s detailed health history to form a precise diagnosis and contributing to the best possible prognosis.
Research
Research programs in pathology contribute extremely valuable data to the medical profession, often identifying new diagnostic markers for advancing the accuracy of patient diagnosis. Our research programs at OHSU are in a state of rapid growth, encompassing projects such as studying bladder cancer and cell invasion, placental mechanisms affecting the health of mother and baby, cutting edge molecular pathology analysis, hematologic malignancies, and neurodegenerative studies with the Oregon Brain Bank. In addition, we are actively recruiting physician scientists to continue to grow our research portfolio, including a partnership with OHSU’s Cancer Early Detection Advanced Research Center (CEDAR), devoted to early detection of breast, pancreas and lung cancers. The majority of our faculty are involved in clinical and translational research projects.
Department News
OHSU Pathology is hiring! If you can see yourself working in a thriving academic environment with truly great people in a spectacular city, we want to hear from you.
Academic Chemistry Lab Director
Academic Breast Pathologist
Assistant Professor
- Greg Scott, MD, PhD is the last author on an article, “Hearing loss, incident Parkinson's disease, and treatment with hearing aids’s”, accepted in JAMA Neurology.
- Amber Halse’s, Laboratory Section Coordinator, abstract "Validation of ELITech Primer and Probes for Adenovirus on Roche’s Cobas 8800 OMNI Channel" has been selected for publication in The Journal of Molecular Diagnostics and for a poster presentation at the annual AMP meeting. Amber collaborated with Drs. Guang Fan & Xuan Qin.
- PGY3 resident Connor Thellman had a Lesson of the Month published with Dr. Ozlen Saglam in Histopathology on NTRK fusions in cervical sarcoma, and his team’s mock R01 grant on wildfire smoke exposure in pregnancy won first place at OHSU’s Developmental Origins of Health and Disease with Dr. Terry Morgan.
- 2023-2024 Hematopathology fellow Dr. Eric Chen’s abstract "Flow Cytometric Detection of Cytoplasmic CD3 Expression and Intensity in Acute Leukemias” has been selected for a poster presentation at the annua ICSS meeting. Eric was mentored by Dr. Wei Xie.
- 2023-2024 Hematopathology fellow Trent Irwin’s abstract "Validation of the Cepheid Xpert® BCR-ABL Ultra p210 and p190 Assays in Peripheral Blood and Bone Marrow Specimens" has been selected for publication in The Journal of Molecular Diagnostics and for a poster presentation at the annual AMP meeting. Trent was mentored by Dr. Wei Xie.
